Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic drug monitoring and continuous infusion of beta-lactam antibiotics in patients with bacteraemia
2015-002562-23Phase 4Terminated
- Sponsor
- Hvidore Hospital
- Start
- Apr 2017
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of benzylpenicillin, dicloxacillin, ampicillin, cefuroxime, meropenem and 1 more in Bacteremia and bacterial disease (2 arms), sponsored by Hvidore Hospital. Primary endpoint: Serum concentrations within target values. Started Apr 2017; status: terminated.
02
Drugs
benzylpenicillindicloxacillinampicillincefuroximemeropenem
03
Conditions
Bacteremiabacterial disease
Beyond the preview
Go deeper on 2015-002562-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002562-23.